DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20195783

A comparative clinical study on efficacy of terbinafine and griseofulvin in patients with tinea corporis

G. Muthu Kavitha, M. Shanthi, M. S. Ahil

Abstract


Background: The objective of the present study was to compare the efficacy of terbinafine and griseofulvin in patients with tinea corporis in a tertiary care hospital, Madurai.

Methods: About 60 patients are selected from the outpatient department of Dermatology according to inclusion and exclusion criteria. They were divided into 2 groups of 30 patients each. Group 1 received tab. terbinafine 250 mg OD and group 2 received 250 mg BD for 4 weeks. All patients were investigated at baseline, end of 2nd week and at end of 4 weeks. Effectiveness of both the drugs were determined by achieving clinical as well as mycological cure. The results were recorded, tabulated and analysed using student’s t test.

Results: Patients in group 1 showed higher clinical and mycological cure rate when compared with group 2.

Conclusions: Oral terbinafine is the effective antifungal agent in the treatment of extensive tinea corporis infection.


Keywords


Terbinafine, Griseofulvin, Tinea corporis

Full Text:

PDF

References


Kanwar AJ, Dipankar De. Superficial Fungal Infections. In: Valia RG, Valia AR, eds. Textbook of Dermatology, 3rd ed. Mumbai: Bhalani Publishing House; 2008: 252-290.

Hay RJ. Ashbee HR. Mycology. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology. 8th ed. London: Wiley-Blackwell Publication; 2011;2(36):18-50.

Bennett JE. Antifungal agents. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman’s The Pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill; 2011: 1571-1592.

Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Antifungal agents. Rang and Dale’s Pharmacology. 7th ed. Toronto: Elsevier; 2012: 649-653.

MacDonald E, Head ES. Introduction to fungal infections. In: Demis DJ, ed. Clinical dermatology. Philadelphia: JB Lippincott; 1989: section 17.1.

Hay RJ, Roberts SOB, Mackenzie DWR. Mycology. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of dermatology. Oxford: Blackwell Scientific Publications; 1992: 1128.

Jyothi N, Judith J, Nirmaladevi P. A Study on cutaneous infections among adults at the dermatology outpatient department in a rural tertiary care center. Tirunelveli J Med Sci. 2013;5:112-3.

Gupta AK. Systemic antifungal agents. In: Wolverton SE, eds. Comprehensive Dermatologic Drug Therapy, 3rd ed. USA: Elsevier publication; 2013: 98-119.

Chander J. Dermaptophytoses. In: Chander J (ed). Text book of Medical Mycology. 3rd edition. New Delhi: Mehta Offset Pvt Ltd; 2009: 122-142.

Venkatesan G, Singh AJAR, Murugesan AG, Janaki C, Shankar GS. Trichophyton rubrum– the predominant etiological agent in human dermatophytoses in Chennai, India. Afr J Microbiol. 2007;5:9-12.

Voravutinon V. Oral treatment of tineacorporis and tineacruris with terbinafine and griseofulvin: a randomized double blind comparative study. J Med Assoc Thai. 1993;76:388-93.

Beller M, Gessner BD. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J Am Acad Dermatol. 1994;31:197-201.

Padhye AA, Summerbell RC. The Dermatophytes. In: Merz WG, Hay RJ, eds. Topley Wilson’s Medical Mycology, 10th ed. London: ASM Press; 2005: 220-238.